[{"NetIncomeLoss_1_Q1_USD":-27824000.0,"InvestmentOwnedBalanceShares_0_Q1_shares":0.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":19764000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":35000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":38083000.0,"Depreciation_1_Q1_USD":48000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":16234000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":33000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":988000.0,"AssetsCurrent_0_Q1_USD":215264000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":17000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":962000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":212779000.0,"Assets_0_Q1_USD":258608000.0,"ShareBasedCompensation_1_Q1_USD":1794000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":5163000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":16234000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":69097000.0,"ProceedsFromSaleOfOtherAssetsInvestingActivities_1_Q1_USD":1594000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":323638696.0,"GeneralAndAdministrativeExpense_1_Q1_USD":7478000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":7395000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":34000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":61621000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":1200000.0,"CommonStockValue_0_Q1_USD":318000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":33289000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":21113000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":16263000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1840000.0,"RealizedInvestmentGainsLosses_1_Q1_USD":1233000.0,"RestrictedInvestmentsAtFairValue_0_Q1_USD":363000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-27867000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":31537000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":4672000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1384262000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":17000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-43000.0,"OperatingLeaseLiability_0_Q1_USD":5555000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":34000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":687000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":1014000.0,"OperatingIncomeLoss_1_Q1_USD":-28454000.0,"ProceedsFromWarrantExercises_1_Q1_USD":12000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":937000.0,"LiabilitiesCurrent_0_Q1_USD":28552000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":21612000.0,"AccountsPayableCurrent_0_Q1_USD":4459000.0,"InterestExpense_1_Q1_USD":743000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3115000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":22999000.0,"LongTermDebtNoncurrent_0_Q1_USD":24222000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q1_USD":374000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":22999000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":31900000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_1_Q1_USD":25000.0,"IncreaseDecreaseInOperatingLiabilities_1_Q1_USD":-2515000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":69097000.0,"IncreaseDecreaseInOperatingAssets_1_Q1_USD":3757000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":620000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-32734000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":1794000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":68000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":25122000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":179490000.0,"InvestmentIncomeInterest_1_Q1_USD":173000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":258608000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":3446000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":1794000.0,"NontradeReceivablesCurrent_0_Q1_USD":759000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":883000.0,"OperatingExpenses_1_Q1_USD":28591000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":137000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":363000.0,"ProfitLoss_1_Q1_USD":-27824000.0,"ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity_1_Q1_USD":25000.0,"StockholdersEquity_0_Q1_USD":201162000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":10000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":212744000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-416000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":180000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1183453000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.09,"GainLossOnSaleOfEquityInvestments_1_Q1_USD":1233000.0,"Ticker":"GERN","CIK":"886744","name":"GERON CORP","OfficialName":"Geron Corporation Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"565597388.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]